about
Risk factors of osteoporosis in healthy Moroccan men.The discriminative ability of FRAX, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study.Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women.Relationships between vertebral fractures, sex hormones and vitamin D in Moroccan postmenopausal women: a cross sectional studyInvolvement of the foot in patients with psoriatic arthritis. A review of 26 cases.Prevalence and Risk Factors of Discordance between Left- and Right-Hip Bone Mineral Density Using DXA.Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?Influence of obesity on vertebral fracture prevalence and vitamin D status in postmenopausal women.Pleuropulmonary involvement in ankylosing spondylitis.Monitoring of dual-energy X-ray absorptiometry measurement in clinical practice.Discordance in diagnosis of osteoporosis using spine and hip bone densitometry.DXA scanning in clinical practice.Osteoporosis in patients with primary biliary cirrhosis.Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications.Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review.Vertebral fractures and abdominal aortic calcification in postmenopausal women. A cohort study.Relationship between vertebral fracture prevalence and abdominal aortic calcification in men.Homocysteine, folate, and vitamin B12 levels and vertebral fracture risk in postmenopausal women.Vertebral fracture assessment in asymptomatic men and its impact on management.The relationship between sex steroids, bone turnover and vertebral fracture prevalence in asymptomatic men.Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women.Vertebral fracture assessment in Moroccan women: prevalence and risk factors.Taxonomy of rare genetic metabolic bone disorders.Prevalence and risk factors of osteoporosis in patients with Parkinson's disease.Age-adjusted incidence rates of hip fractures between 2006 and 2009 in Rabat, Morocco.Epidemiology of hip fractures in 2002 in Rabat, Morocco.Cervical spine involvement in ankylosing spondylitis.Polymorphisms of HLA-A, -B, -Cw and DRB1 antigens in Moroccan patients with ankylosing spondylitis and a comparison of clinical features with frequencies of HLA-B*27.Performance of the osteoporosis risk assessment tool in Moroccan men.[McDuffie hypocomplementemic urticarial vasculitis. Two cases and review of the literature].Does Rheumatoid Cachexia Predispose Patients with Rheumatoid Arthritis to Osteoporosis and Vertebral Fractures?Prevalence and risk factors of discordance in diagnosis of osteoporosis using spine and hip bone densitometry.Thoracic high resolution computed tomography in patients with ankylosing spondylitis and without respiratory symptoms.Idiopathic retroperitoneal fibrosis and ankylosing spondylitis. A new case report.Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis.[Ankylosing spondylitis].Bone metabolism in male patients with type 2 diabetes.Erdheim-Chester disease: a case report with pulmonary, kidney involvement and bone lesions.Rheumatoid nodulosis: a new case report.Body mass index and gynecological factors as determinants of bone mass in healthy Moroccan women.
P50
Q33625410-BB7F6E69-B5F6-4A73-82C2-D2FD32F78C0FQ34484663-6F3126C0-C6C9-47ED-BAE5-7E08AD2132C4Q34721213-99EA6168-019E-4F90-BCE7-48CACBFD6597Q35618976-028C401C-061E-4E7A-B073-B20B1738C607Q35979206-6172B5C6-F89B-4C6A-B925-153831D12CD9Q36063537-7730531C-9C82-41AB-9A0E-913D2C31C3B3Q36073054-CC895459-E514-43DE-9431-92DB1DEBF4EBQ36292651-28AAF7D4-AACD-46DB-8467-1777D0946D9BQ36352903-F16B7B89-7385-432B-8F53-20C6198397E8Q36576504-649CB1C4-20C4-4E8F-80D1-264C7FAB2D0EQ36813509-1DFA5DDA-3FCA-4DCD-AFF0-224C88B27F63Q37107665-30E2D23E-07DF-4E2B-82B3-DE8EA0AB57F2Q37798429-A9D1D11E-F1DA-4EF9-865A-ADBB6E1B20C5Q37954890-C14D3DCC-9C50-4D06-98DA-D1B609D93F44Q38005700-0E360405-CCF8-4E28-ACB3-90B5EE4EE9AEQ38449599-AE0FBEED-D131-40C8-B5CA-9E8405867829Q38461967-F7962DDC-1433-4561-9E5A-B5A3EAF41A11Q38465576-E39F7A2D-9AA7-4C28-A36D-76C42D998B2EQ38466606-9C25DC5F-6CF4-491E-A4B8-DD6DB9272F9DQ38472670-4C6E9981-76FB-47F5-9B7D-58AACFF3F871Q38482929-D4279183-4FE1-4265-8028-2CB5756CEA89Q38497079-B5097133-C951-4B54-8218-28906150A612Q38526438-22CF03DE-738B-4159-A054-D85807BBCEA7Q38907177-49A6DA51-E185-43BA-A050-0E66F85CB2A0Q38985038-2CA6A022-2403-4B0C-A5FC-8582FFDC282AQ38985053-C0555E6B-B053-4329-BD39-EAECD1AD3AAAQ38985057-FAB88EA8-E20D-4610-BF75-4C2290C100ABQ38985290-AFA08048-6BCF-4C30-B7F8-9FD3E35D5085Q39022031-9EC7FE27-07BB-42AB-B231-E4012BCF01D0Q40607420-88576D34-17CF-4FDB-BD06-2D0ABF26E5F2Q41522953-9EDC141D-176D-4B04-AFD2-2F6F462B7627Q42955103-E81FF874-3DB3-4890-B29F-4ED79B4644F2Q43050643-668C4413-A65B-4362-B1E9-496458B0F140Q44245665-7AE9ABA0-263E-4DA2-9CB1-88F8A88F9C30Q45183754-B3BE2C1B-E35D-46E6-A88C-778239BB8A7AQ45196205-FFE7CA43-2671-41EC-9563-3036F1B205B7Q45300536-543BF3F1-BDC6-4B17-B48B-9FAB27C308BCQ45934664-702CB41D-B8E5-4B36-A893-5AC5AD29AD95Q46201391-FADE105C-3B7A-4C75-A23F-A06BF31D6B59Q46209469-A6BAB708-646B-4E87-A582-4607F419BD32
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Abdellah El Maghraoui
@ast
Abdellah El Maghraoui
@en
Abdellah El Maghraoui
@es
Abdellah El Maghraoui
@nl
type
label
Abdellah El Maghraoui
@ast
Abdellah El Maghraoui
@en
Abdellah El Maghraoui
@es
Abdellah El Maghraoui
@nl
altLabel
A El Maghraoui
@en
prefLabel
Abdellah El Maghraoui
@ast
Abdellah El Maghraoui
@en
Abdellah El Maghraoui
@es
Abdellah El Maghraoui
@nl
P106
P1153
7004260341
P21
P31
P4012
P496
0000-0003-0668-5680